CERVIX | CERVICAL SCREENING [ISSN 1804-087X]
česky | english | sitemap


PARTNERS AND EXPERT GUARANTEE
 
Czech Gynaecological and Obstetrical Society | Ministry of Health | Institute of Biostatistics and Analyses, Masaryk University
GRANT SUPPORT OF THE PROJECT
 
GlaxoSmithKline     Roche |

Other sources of information
Cervical cytology (in Czech)www.cipek.cz
Cervical cytology
 
Cancer Screening in the European Unionec.europa.eu
Cancer Screening in the European Union (2017)
[ 10,6 MB]
 
SVOD - Epidemiology of malignant tumours in the Czech Republicwww.svod.cz
Epidemiology of malignant tumours
in the Czech Republic
 
NCI Bethesda System
HPV College

 

HIV drug lopinavir 'may prevent cervical cancer' by targeting the virus that causes the disease

A commonly used HIV treatment could prevent cases of cervical cancer by killing off cells infected with the human papillomavirus (HPV), according to a new laboratory study.


Research by a team from the University of Manchester and colleagues in Canada indicates that the antiviral drug lopinavir attacks HPV - which causes almost all cervical cancer - by 'switching on' the natural defences in infected cells.

The study, published in the journal Antiviral Therapy, follows earlier research by the team, which identified the drug as a potential preventive treatment for cervical cancer in 2006, following laboratory tests on cells.

Read the whole article at Cancer Research UK

Reference

  1. Batman, G., Oliver, A., Zehbe, I., Richard, C., Hampson, L., & Hampson, I. (2011). Lopinavir up-regulates expression of the antiviral protein ribonuclease L in human papillomavirus-positive cervical carcinoma cells Antiviral Therapy DOI: 10.3851/IMP1786

5.5.2011 Cancer Research UK


Back